Avecho Biotechnology Limited (ASX:AVE)

Australia · Delayed Price · Currency is AUD

0.0090

-0.0005 (-5.26%)

At close: Mar 27, 2026

Revenue by Segment

Financials in millions AUD. Fiscal year is January - December.

Millions AUD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Production	1.24M	1.13M	473.55K	1.13M	786.10K
Production Growth	9.28%	139.19%	-58.07%	43.65%	139.68%
Human Health	-	-	-	-	7.50K
Human Health Growth	-	-	-	-	-86.76%
Total	1.24M	1.13M	473.55K	1.13M	793.60K
Total Growth	9.28%	139.19%	-58.07%	42.30%	106.33%

Revenue by Geography

Financials in millions AUD. Fiscal year is January - December.

Millions AUD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Australia	136.98K	38.17K	38.31K	24.55K	96.30K
Australia Growth	258.90%	-0.37%	56.04%	-74.51%	2248.76%
Switzerland	1.07M	352.62K	403.44K	1.01M	583.46K
Switzerland Growth	203.02%	-12.60%	-60.05%	73.10%	80.14%
Americas	-	708.54K	-	-	-
India	22.50K	33.34K	31.80K	25.50K	113.84K
India Growth	-32.52%	4.85%	24.70%	-77.60%	100.99%
France	9.75K	-	-	-	-
United States	-	-	-	69.26K	-
Total	1.24M	1.13M	473.55K	1.13M	793.60K
Total Growth	9.28%	139.19%	-58.07%	42.30%	106.33%

Source: S&P Global Market Intelligence.